ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth

Contributed by: Business Wire

Logo

Business Wire logo

Images

ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth
Business Wire embedded0

Tags

Science
Biotechnology
Research
Pharmaceutical
Oncology
General Health
Health
Clinical Trials
Appointment

More Like This

EQT Life Sciences leads €54 Million Series A Financing of ATB Therapeutics

Mark Rothera, CEO TreeFrog Therapeutics

TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth

Mark Pugh Appointed New CEO of Theragenics Corporation (Photo: Business Wire)

Mark Pugh Appointed CEO of Theragenics Corporation

PR Newswire associated0

Telum Therapeutics appoints Dr. Subhendu Basu as CEO

PR Newswire associated0

Tagworks Pharmaceuticals Appoints Ken Mills as Chief Executive Officer

Business Wire logo

Byondis Appoints Christoph Korpus, PhD, MBA as Chief Executive Officer

Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer

PR Newswire associated0

TFS HealthScience Announces Leadership Transition: Katarina Ageborg Appointed Chairman of the Board, Markus Granlund Named Acting CEO